Robin Miskel didn’t start her Sanofi US career working in the company’s Rare Diseases group, but after supporting her mother through a life-threatening diagnosis, she was inspired to work more closely with patients. Today, Robin is enjoying her new position as a Care Coordination Case Manager Specialist for Sanofi Genzyme’s US Rare Diseases.
This post was authored by Lisa Egbuonu-Davis, M.D., Vice President, Global Patient Centered Outcomes & Solutions, who, in honor of Black History Month, shares her story about why she is committed to supporting gifted students from underrepresented minorities and socioeconomic disadvantaged groups. Lisa is a graduate of the Johns Hopkins School of Medicine and Bloomberg School of Public Health.
Sanofi US continues its efforts to complete the return and reimbursement process associated with the October 28, 2015, voluntary nationwide product recall of Auvi-Q® (epinephrine injection, USP).
Last update: December 14, 2016